INTRODUCTION

In the 1960s, van Furth and Cohn used labeling with [
3 H] thymidine to define kinetics of monocyte transit in the bloodstream. Monocytes spent at most a few days in blood and then mobilized to various tissues, including the inflamed peritoneum (van Furth and Cohn, 1968) . In their view, the data indicated that monocytes continuously replenished tissue-resident macrophages. The concept was supported by the relative ease with which monocytes became macrophages in culture (van Furth and Cohn, 1968) , and more recent data specifically point to the Ly-6C + subset of monocytes (Wynn et al., 2013) as precursors for macrophages in inflammatory settings. Beginning in the mid-1990s, arguments developed that the fate of monocytes could be diverted from becoming macrophages and redirected to that of dendritic cells (DCs), if appropriate signals were encountered (Iijima et al., 2011; Leó n et al., 2007; Nakano et al., 2009; Sallusto and Lanzavecchia, 1994; Serbina et al., 2003; Wakim et al., 2008) . This differentiation, like the evidence for monocyte conversion to macrophages in vivo, stemmed almost entirely from scenarios involving inflammation. After the work of Van Furth and Cohn, an alternative possibility that macrophages renewed themselves by local proliferation rather than dependence upon monocytes was presented (Coggle and Tarling, 1984; Sawyer et al., 1982) . This viewpoint was difficult to reconcile with the concept of monocytes as precursors of macrophages and it failed to gain major traction without stronger evidence than existed at the time. Recently, definitive studies have been carried out on the origin of tissue-resident macrophages, starting with brain macrophages (Ginhoux et al., 2010) and then extending to many other organs (Hashimoto et al., 2013; Schulz et al., 2012; Yona et al., 2013) . The data clearly indicate that in most organs, resident macrophages are derived embryonically and maintain themselves in adults by self-renewal. An exception is observed in the intestine where macrophages are continuously repopulated by circulating monocytes (Zigmond and Jung, 2013) .
These recent findings, therefore, alter a key aspect of the model that the field has held on the life cycle of monocytes since the 1960s and raise new questions about the biology of monocytes and whether they indeed extravasate constitutively (Wynn et al., 2013) . Here, we asked whether monocytes extravasate into steady-state tissues. Upon finding such monocytes, we addressed their differentiation status. Our results support a revised paradigm wherein extravasated monocytes in noninflamed tissues retain much of their monocytic character, rather than differentiating to macrophages or DCs. Even so, they survey tissue for antigens for transport to draining lymph nodes (LNs).
RESULTS
Classical Monocytes Are Present in Resting
Nonlymphoid Tissues and Lymph Nodes CD64 (FcgR1) selectively recognizes macrophages, and Mer tyrosine kinase (MerTK) is an additional macrophage-selective marker Tamoutounour et al., 2012) . Not previously tested in skin, MerTK identified dermal macrophages as well, in contrast to isotype-matched control Ab (Figure S1A available online). Costaining for MerTK and CD64 marked macrophages ( Figure 1A ) but excluded DCs and monocytes. Although monocytes express CD64 (Ingersoll et al., 2010) , they do not express MerTK ( Figure 1B ). Skin DCs were identified as remaining MerTK À
CD64
À cells expressing high CD11c and major histocompatibility complex class II (MHCII) molecules ( Figure 1A) . Then, by gating on cells that were neither macrophages nor DCs, monocytes were identified in skin. Gating on remaining CD11b + cells revealed two populations of F4/80 lo cells, with low and higher side scatter (SSC), respectively, and a high SSC population lacking F4/80 ( Figure 1A ). The latter were neutrophils, whereas F4/80 lo high-SSC cells were eosinophils Figure 1A ). All identified monocytes expressed Ly-6C and most expressed MHCII ( Figure 1A) . Use of the same strategy in digested lymph node (LN) ( Figure S1B ) and lung ( Figure 1C ) permitted identification of monocytes in these locations. In all tissues, monocytes accounted for all low-SSC, CD11b hi cells with low to intermediate CD11c ( Figures   1A, 1C , and 1D). Macrophages and DCs were larger and had more granular cytoplasm resulting in greater SSC than monocytes, consistent with properties expected of bona fide monocytes ( Figure 1D ). The frequency of extracted monocytes was roughly equal to macrophages in nonlymphoid tissues (Figure S2 ), whereas we extracted fewer macrophages from LNs than monocytes. These ratios may underestimate macrophages, notoriously challenging to extract. LN monocytes were one-tenth the frequency of total LN DCs ( Figure S2 ) but were similar in frequency to migratory, lymph-derived DCs in resting LNs (Jakubzick et al., 2008a) . Taken together, we conclude that classical monocytes constitutively populate noninflamed tissues, where they express MHCII.
Extravascular Monocytes Resemble MHCII + Blood
Monocytes Classical monocytes are thought to lack MHCII (Geissmann et al., 2003; Ingersoll et al., 2010) . Detection of MHCII + monocytes in tissues and LNs prompted us to re-examine blood for MHCII + monocytes. A minority of monocytes were MHCII + . These were high or intermediate for . Because MHCII + monocytes showed a spectrum of Ly-6C expression, it was optimal to divide monocyte subsets according to CD43 (leukosialin) expression rather than Ly-6C ( Figure 2A ). CD43 differentially defines the major subsets of monocytes in all species examined to date (Ziegler-Heitbrock, 2007 (Geissmann et al., 2003) , gates 1-3 of blood CD43 lo monocytes displayed a graded increase in GFP intensity ( Figure 2C ) that correlated positively with MHCII but inversely to Ly-6C. In CD43 hi monocytes (gates 4 and 5), GFP intensity was characteristically high (Geissmann et al., 2003) regardless of MHCII ( Figure 2C ). Monocytes in tissue and LNs had overlapping GFP intensity with monocytes in blood that were Ly-6C + MHCII + (gate 2) ( Figure 2D ). Furthermore, in Lyz2-cre 3 RosaEGFP flox/+ reporter mice, the frequency of GFP + cells differs between monocyte subsets (Jakubzick et al., 2008a Figure 2E ) but were distinct in frequency from CD43 lo monocytes ( Figure 2E ; Jakubzick et al., 2008a inflammatory DCs (Aldridge et al., 2009; Nakano et al., 2009; Serbina et al., 2003) . Principle component analysis by means of data available from Immgen (http://www.immgen.org) revealed that LN monocytes clustered most closely with blood monocytes ( Figure 3A ). Analyzed DCs included Langerhans cells (LCs), other migratory DCs in skin-draining LNs (SLNs) ( Figure 3A) , and LNresident CD4 + and CD8 + DCs ( Figure 3A ). Lymph-migratory
DCs from distinct sources clustered Figure 1C ). Lung monocytes clustered with LNs and blood monocytes more closely than with either macrophage population ( Figure 3B ). A few dozen mRNA transcripts were elevated R3-fold in tissue monocytes relative to blood. Many of these transcripts were upregulated in common between lung and LN monocytes, pointing to a common signature induced upon monocyte entry into tissues ( Figure 3C , Table S2 ). This signature included Ptgs2 encoding cyclo-oxygenase 2 (COX-2), Il1b encoding interleukin 1-b, Tnfaip3 encoding A20, and Itgax encoding CD11c ( Figure 3C ). CD11c was not expressed on Ly-6C + blood monocytes (Ingersoll et al., 2010) but was observed on tissue monocytes, albeit lower than on DCs (Figure 1 ). Immunostaining analysis revealed COX-2 in Ly-6C + mononuclear cells in lung parenchyma ( Figure 3D ), indicating expression of COX-2 in lung monocytes, along with its expression on neighboring DCs that were detected as cells expressing more MHCII in the lung than tissue monocytes ( Figure 3D ). Ptgs2 mRNA is expressed by CD11b + CD24 + DCs in the Immgen database, fitting with these results. Some transcripts were upregulated only in lung or LN monocytes (Table S2 ). Flow cytometry for chemokines (Eberlein et al., 2010) whose transcripts were upregulated only in LN and not in lung monocytes, including CCL5 and CXCL10, stained LN monocytes more distinctly than lung monocytes ( Figure 3E ). An interferon (IFN) signature was observed in LN but not lung monocytes (CXCL9, CXCL10, etc.) (Table S2) . Neutralizing IFN-g did not reduce MHCII on blood monocytes ( Figure S3C ) and mice lacking IFN-g and type I IFN receptor also retained MHCII + blood monocytes (data not shown).
Thus, tissue monocytes derived from steady-state organs closely resemble blood monocytes, rather than macrophages or DCs. The persistence of monocytes as bona fide monocytes in tissues probably applies only to steady-state tissues because monocytes recruited to sites of inflammation differentiated into macrophages and clustered with macrophages resident in that organ. Figure 3A ) clustered with resident Figure S3 and Tables S1 and S2 accompany this figure.
macrophages. Perhaps monocytes that enter tissues on an ongoing steady-state basis fail to differentiate to macrophages but remain similar to blood monocytes that have been activated, whereas in inflammation, they differentiate to macrophages. To evaluate this idea, we next sought more information on the tissue monocyte life cycle in the steady state.
Life Cycle and Fate of Extravascular Monocytes
We depleted blood monocytes by using i.v. liposomal clodronate that nearly completely depleted blood monocytes for 1 day with a gradual recovery thereafter ( Figure 4A ). In lung, extravascular tissue monocytes persisted for up to 3 days after monocytes were depleted ( Figure 4A ). Monocyte frequency in these tissues was normalized to that of B cells, because B cells are not targeted for depletion. When we normalized to total CD45 + cells or total cells recovered, similar results were obtained. In SLNs, monocyte numbers also did not dip significantly for 3 days (Figure 4B ). However, in MLNs, depletion of blood monocytes reduced LN monocytes by half in 1 day ( Figure 4B ), with slow recovery in parallel with blood ( Figure 4B ). We next pulsed mice with bromodeoxyuridine (BrdU) i.p. To be sure that tissue monocytes evaluated were not mixed with blood monocytes that remained within the vasculature of tissues as they were processed, we injected anti-CD45 mAb i.v. 2 min before euthanasia. This technique was effective in skin and LNs where most typically we found no lingering blood monocytes but occasionally a minor fraction ( Figure 4C ). The method was not useful in lung; resident DCs were labeled as were lung monocytes ( Figure 4C ), indicating that anti-CD45 mAb readily accessed the highly vascularized lung. However, persistence of lung monocytes after i.p. injection of liposomal clodronate and the general lack of blood monocyte contamination in other tissues suggested that lung monocytes were not heavily contaminated. Tissue monocytes did not proliferate in situ; there were very few BrdU + monocytes in the various organs 2 hr after BrdU was given ( Figure 4D ). Peak labeling occurred in blood at 24 hr when nearly half of monocytes were BrdU + ( Figure 4D ). At 48 hr, the frequency of BrdU + lung and MLN monocytes mirrored that of blood ( Figure 4D ). SLN monocytes might be in part derived from skin monocytes emigrating to the LN from skin lymphatics ( Figure 4D ). The frequency of BrdU labeling in macrophages from skin and lung CD11b À or CD11b + macrophages was distinct from monocytes and consistent with a low, basal rate of proliferation that was somewhat higher in CD11b + macrophages compared with the more prominent CD11b À lung macrophage population (Figure S5 ). Because by day 10, all BrdU + monocytes had entered and been cleared from each tissue, we were confident that we had identified a sufficient frame of time (10 days) to track a full tissue monocyte life cycle in skin, lung, and different LNs.
We next wondered whether some monocytes in these tissues differentiated to macrophages. Few macrophages were extracted from LNs ( Figure 1C ), so we focused on macrophages in the lung, where two subpopulations are clearly evident (Figure 1D) , and on skin macrophages. Although the main population of lung macrophages is embryonically derived (Hashimoto et al., 2013; Yona et al., 2013) , the life cycle of the CD11b + lung macrophages has not been studied in detail. We carried out parabiosis between CD45.1 and CD45.2 WT partners or WT and Ccr2
À/À partners, where WT monocytes efficiently repopulate the Ccr2 À/À host (Hashimoto et al., 2013) , examining chimerism at 2 weeks and 1 year after parabiosis. Neither macrophage population (CD11b À or CD11b + ) were replenished by circulating cells, although tissue monocytes between parabionts efficiently exchanged ( Figure 4E ). When we separately analyzed macrophages in alveolar lavage, the same outcome was observed. In skin, by contrast, macrophages were partially replenished by circulating precursors derived from the partner parabiont at 2 weeks ( Figure 4F , left graph) and nearly fully by 1 year (Figure 4E , right graph), suggesting that monocytes are critical precursors for skin macrophages. We conclude that monocytes enter some organs like lung constitutively for purposes other than to replenish macrophages. Recent data also suggest they do not give rise to DCs in the lung (Satpathy et al., 2012) . Thus, the life cycle of monocytes can include trafficking into tissues without obligatory differentiation to macrophages or DCs. These observations raised the question as to whether monocytes failing to become macrophages complete their life cycle as local monocytes that eventually die or whether they might move out of the tissue by emigrating to draining LNs, which we set out to test.
Monocyte Trafficking to Tissues Is Not Driven by Commensal Bacteria
The frequency of monocytes in MLNs and SLNs was greater than in lung-draining mediastinal LNs ( Figure 5A ). Therefore, we wondered whether tissues in contact with microbiota (skin and gut) recruited Ly-6C + MHCII + monocytes resulting from mild commensal-driven inflammatory signals. However, the frequency of Ly-6C + MHCII + monocytes in the LN ( Figure 5B ) or skin ( Figure 5C ) was similar between germ-free and conventionally housed mice. Extravascular neutrophils were also found in skin ( Figure 1A ), but in contrast to monocytes, their recruitment was significantly reduced in germ-free mice ( Figure 5D ). Finally, monocyte subset frequency in the blood of germ-free mice showed a greater proportion of Ly-6C + monocytes ( Figure 5E ), though total monocyte numbers were not different between germ-free and conventionally housed mice, indicating that the development of Ly-6C
À monocytes from Ly-6C + monocytes Figure 6A ) and LNs ( Figure 6B ). By contrast, LN Ly-6C + MHCII + monocytes were elevated in plt/plt (mice lacking CCR7 ligands) and Ccr7 À/À mice, consistent with previous studies ( Figure 6B ; Nakano et al., 2009 Figure 6B ). However, when chimeric mice were generated by using lethally irradiated recipient mice reconstituted with a 1:1 mixture of CD45. -derived monocytes selectively showed a modest disadvantage in gaining access to skin-draining LNs ( Figure 6C -derived monocytes may be due to a passage of monocytes across HEV from the bloodstream and also an impact on monocyte trafficking first into skin and subsequently to LNs through afferent lymphatics. To investigate the migration of undifferentiated monocytes to LNs through afferent lymphatics, we adoptively transferred purified Ly-6C (Figure 6F ). In LNs, these cells had lost Ly-6C expression, seemingly different than our observations for endogenous monocytes, but this may be due to having sorted on monocytes using Ly-6C mAb that may have stimulated internalization of surface Ly-6C. Emigration of transferred MHCII + monocytes from skin to SLNs ( Figure 6F ) and data from BrdU labeling consistent with this concept ( Figure 4E ) led us to wonder whether steady trafficking monocytes might survey tissues and transfer antigens to LNs, all the while retaining close resemblance to monocytes (Figure 3 ). We used an experimental approach in which FITCconjugated lipopolysaccharide (LPS)-free chicken ovalbumin (OVA) administered i.n. quantitatively tracks trafficking of DCs to LNs in the steady state (Jakubzick et al., 2008b) . We asked whether monocytes also acquired FITC-OVA in the lung and transported it to the lung-draining lymph node (LLN) in the absence of inflammation, how this transport compared quantitatively to migration of DCs transporting FITC-OVA, and how inflammation in the lung affects transport of FITC-OVA by minimally undifferentiated monocytes. For these assays, we relied on previous insight that some sources of chicken OVA induce inflammation but other sources do not perturb steady-state leukocyte trafficking (Jakubzick et al., 2008b ). Approximately Figure S5 accompanies this figure.
6% of monocytes gated in LNs were FITC-OVA + at 24 hr after FITC-OVA was administered i.n. (Figure 6G ), thus indicating that monocytes in the LN at least are partly sustained through lymphatic input of monocytes. Furthermore, these data show that monocytes participate in antigen surveillance in upstream peripheral tissues and emigrate with this antigen to LNs without differentiating to cells other than monocytes (such as DCs or macrophages Figure S6 ). When inflammation-inducing OVA was used to analyze antigen-trafficking monocytes to the draining LN, the fraction of labeled monocytes approximately doubled but still left DCs dominant in overall antigen transport ( Figure 6G ).
To provide an infectious context with more robust inflammation, we inoculated anthrax spores into the airway. CFSE was delivered i.n. 2 or 3 days after spore delivery. CFSE administered i.n. does not enter freely into the LNs (Jakubzick et al., 2008b Figure 7A ). Ly-6C À monocytes failed to enter SLNs ( Figure 7B ) but trans- Figure 7B ). Thus, entry into the LN is not restricted to MHCII + blood monocytes. Transferred cells were difficult to retrieve from the skin, but those that were retrieved from transfer of Ly-6C + MHCII À monocytes also showed induction of MHCII after, or in concert with, their arrival in the skin ( Figure 7C ), whereas Ly-6C À monocytes did not enter skin ( Figure 7C ). Figures 7A-7C ) seemed at odds with the finding that injecting these cells directly into skin did not lead to their ability to migrate to LNs, because MHCII + monocytes were able to mobilize to LNs (Figure 6 ). Emigration and MHCII expression are known to be coupled (Faure-André et al., 2008) , so we wondered whether direct injection of Ly-6C + MHCII À monocytes in the skin might be associated with a failure of the monocytes to upregulate MHCII. Indeed, Ly-6C + MHCII À monocytes purified from the blood and injected into skin for retrieval 18 hr later did not upregulate MHCII ( Figure 7D ), in contrast to their ability to do so if reinjected in the blood ( Figure 7C ), raising the possibility that conversion of Ly-6C + MHCII À monocytes to Ly-6C + MHCII + monocytes requires migration through or interaction with the endothelium. In support of this possibility, mouse Ly-6C + MHCII À monocytes cultured with endothelial cells, but not fibroblasts, supported a robust upregulation of MHCII ( Figure 7E ). Thus, the appearance of classical monocytes expressing MHCII in tissues arises from the recruitment of MHCII À rather than MHCII + monocytes from blood and the induction of MHCII may be stimulated by transendothelial migration. These monocytes in turn have the ability to survey for antigens in the tissue and emigrate to lymph nodes, all the while remaining as monocytes rather than differentiating to macrophages or DCs.
DISCUSSION
Compelling analysis of lineage indicates that most, if not all, organs contain a population of macrophages derived not from monocytes but from embryonic macrophage progenitors that develop in the embryo before definitive hematopoiesis occurs (Hashimoto et al., 2013; Schulz et al., 2012; Yona et al., 2013) . Schulz et al. (2012) further concluded that all fetal organs contained a second macrophage pool that was of bone marrow origin. The nature of this second macrophage pool was minimally characterized but was defined as a population with lower F4/80 and expression of MHCII, CCR2, and CD11b. Our data indicate that this second pool in organs like lung are not macrophages but rather monocytes that do not contribute to the resident macrophage pool. By contrast, skin macrophages, like intestinal macrophages (Zigmond and Jung, 2013) , appear to derive at least partly from monocytes. The pool of monocytes constitutively entering tissues is not the subset earlier claimed to constitutively traffic into tissues from blood (Geissmann et al., 2003) , as indicated by the fact that we did not identify Ly-6C À
CD43
hi monocytes in extravascular tissues, but instead we found classical Ly-6C + monocytes. Indeed, the concept that resident tissue macrophages are seeded prior to birth raises new questions about the biology of monocytes in the absence of infection or sterile inflammation. Wynn et al. (2013) have raised this question and suggested that monocytes may not enter tissues constitutively, assuming that the raison d'ê tre for doing so no longer applied with the revelation that macrophages derive embryonically. We have shown they do, but not because they are obliged to differentiate to macrophages or DCs after diapedesis. They come into tissues, a step partially dependent upon CD62L, at least in part to survey the environment and then emigrate to LNs, and they are able to do this with only minimal differentiation, such that we are left to best classify them simply as tissue monocytes. Ly-6C + MHCII + monocyte-derived or monocyte-like cells have been given many different names in the literature, including myeloid-derived suppressor cells (Ochando and Chen, 2012) , Tip-DCs (Aldridge et al., 2009; Serbina et al., 2003) , inflammatory DCs (Nakano et al., 2009) , inflammatory monocytes (Soudja et al., 2012) , and effector monocytes (Leiriã o et al., 2012) . Typically in these scenarios when they are studied for their role in antigen presentation, it is in the context of inflammatory reactions (Iijima et al., 2011; Leó n et al., 2007; Nakano et al., 2009; Serbina et al., 2003; Soudja et al., 2012; Wakim et al., 2008) . In LNs, they have been argued to enter through the HEV (Nakano et al., 2009) , with no information on how, after entering via such a route, that they would gain access to the antigen they appear to present. Soluble antigen is largely sequestered in LN conduits, and it appears that sampling of antigen from conduits alone is insufficient to drive a productive immune response (Itano et al., 2003) . In agreement with Ardavin and colleagues (Leiriã o et al., 2012) , we have shown here that monocytes retaining features of minimally differentiated monocytes transport molecules from the nonlymphoid tissues to draining LNs, but we have extended this observation to showing its occurrence in the steady state, with all the while the cells retaining surface and gene expression profiles of monocytes. Consistent with this concept, studies in rat lymph have identified monocytes in resting lymph (Yrlid et al., 2006) , but largely ignored them while focusing on the smaller fraction of those that could be called bona fide DCs. Therefore, monocytes appear to share with DCs the characteristic of tissue surveillance even without becoming DCs. However, the effector mechanisms used by DCs and monocytes need not be the same. Monocytes may support antigen presentation and adaptive immunity by means that do not require they act as the antigen-presenting cell per se. Indeed, when directly analyzed, monocytes displaying Ly-6C, MHCII, and CD11c, perhaps similar to the cells studied here, are poor presenters of antigen (Drutman et al., 2012) , and alternative mechanisms have been identified as to how monocytes potently support adaptive immunity (Soudja et al., 2012) . Thus, we believe that the literature, when combined with our findings, supports a model of the monocyte as a surveillance and effector cell in tissues that is complementary to but does not necessarily duplicate the role of lymph-homing DCs.
Although this work suggests that constitutively trafficking monocytes are not obliged to fully differentiate to macrophages or DCs after they enter tissues, we underscore that monocytes can differentiate to macrophages. Thioglycollate-elicited monocytes, which rapidly lose Ly-6C expression after emigrating from the blood, cluster not with monocytes as do Ly-6C + extravascular monocytes but with resident peritoneal macrophages and they upregulate the genes universally associated with macrophages . It seems from our data that differentiation to macrophages is not obligatory subsequent to monocyte entry, and triggers may be necessary to drive such differentiation. Indeed, the organs wherein macrophages are derived from monocytes in the steady state-skin and intestine-are those that receive stimulation from microbiota continuously. Although infiltration of skin by monocytes was not reduced in germ-free mouse colonies, future studies will be needed to address whether the differentiation of monocytes to macrophages in skin does depend upon microbial stimuli.
The retention of Ly-6C expression in extravascular monocytes may be a convenient signature of cells retaining monocyte status in extravascular tissues. Although more profiling will be needed to establish Ly-6C as such a transitional marker, it is very interesting that recent work in the intestine has tracked the fate of monocytes in different disease scenarios by means of Ly-6C, MHCII, and CD64 expression. In this case, in highly inflammatory scenarios (e.g., colonic inflammation, Crohn's disease), monocytes fail to differentiate beyond the Ly-6C + MHCII + stage, whereas in healthy colon they fully downregulate Ly-6C and become IL-10-producing macrophages (Bain et al., 2013; Tamoutounour et al., 2012) . Gene expression profiles were not identical between blood and extravascular LN monocytes, though they were similar. Prominent among upregulated genes was a common signature between the two tissue monocytes-those from lung and SLN-that we were able to sort in sufficiently large numbers. This included upregulation of mRNA transcripts that are often associated with inflammation and inflammasome or cytokine receptor activation and transcripts often associated with DCs (CD11c, MHCII, CD83). The mRNA transcript encoding COX-2 (Ptgr2), known to be an activation-induced transcript, was expressed in situ, arguing that the common tissue monocyte signature was not a result of activation during isolation and flow cytometric cell sorting. COX-2 has been associated with the monocyte-derived cell's ability to produce PGE2 during infection with Toxoplasma gondii (Grainger et al., 2013) . Such production protects the host against neutrophil-mediated damage (Grainger et al., 2013) and maintenance of tissue integrity. The emergence of COX-2 in the common tissue monocyte signature might suggest that tissue monocytes fulfill this same role, albeit at lower magnitude, in the steady state.
In conclusion, we have identified an extravascular population of classical monocytes in resting tissues that in some organs may account for the previously proposed second population of tissue macrophages (Schulz et al., 2012) . Studies in various reporter mice and gene expression profiling support the concept that in naive tissues, extravascular monocytes differentiate only minimally in the steady state and do not become bona fide macrophages by molecular criteria. Considering that the major populations of resident macrophages do not rely on monocytes as precursors, our data compel us to propose that monocytes be viewed not just as precursors for either macrophages or DCs but as mononuclear phagocytes with functions and roles in their own right-cells with the option, but not the obligation, to differentiate to macrophages in response to cues that remain to be defined.
EXPERIMENTAL PROCEDURES
Mice and Treatments C57BL/6 mice were used at 6-8 weeks of age according to protocols approved by Mount Sinai School of Medicine, University of Colorado, NIAID, or Washington University. Strains were from Jackson Laboratory, except germ-free (GF) mice that were bred at the Washington University Digestive Diseases Core Center or maintained in isolators at the NIAID gnotobiotic facility. Parabiosis was carried out as described (Hashimoto et al., 2013) . For BrdU labeling, mice were injected with 1 mg of BrdU (Life Technologies Corporation) i.p. and then euthanized at the indicated time points. BrdU incorporation into DNA was detected with the BrdU Staining Kit (eBiosciences).
Tissue Preparation and Flow Cytometry
Perfused tissues were minced. Lung and LNs were digested with 2.5 mg/ml collagenase D (Roche) for 30 min at 37 C. Skin was digested in RPMI 1640 plus 1.75 mg/ml Liberase TM (Roche) at 37 C for 25 min. These mAbs and isotype-matched control mAbs purchased from Biolegend were used for flow cytometry staining: Pacific blue-conjugated mAbs to I-A and I-E or Gr1; PE-conjugated mAbs to CD115, Siglec F, CD11b, CD8, CD103, or I-A and I-E; PerCP-Cy5.5-conjugated mAbs to Ly-6C, CD11b; PE-Cy7-conjugated mAb to CD43, CD11c; allophycocyanin-conjugated mAbs to Ly-6C, CD93, CD103, Gr1, CD64, or I-A and I-E; and allophycocyaninCy7-conjugated mAbs to B220, NK1.1; FITC-conjugated mAbs to CD43 or CD36. F480-FITC was purchased from Serotec. Anti-MerTK was from R&D Systems. Chemokine expression was analyzed as described (Eberlein et al., 2010) . As part of ImmGen, for cell sorting, we followed procedures are outlined in extensive detail at http://www.immgen.org. In brief, to sort blood monocytes, staining for CD115, CD43, Ly-6C
À MHCII was done to identify monocyte subsets. FSC-W and dump-channel staining for NK1.1, CD3, and B220 were used to improve purity. Lung and LN monocytes were stained similarly but with MerTK, CD64, F4/80, and CD11b instead of CD115, which is lost after collagenase digestion. Lung or LNs were digested in Collagenase D (Roche) for 30 min at 37 C and cells were stained with conjugated mAbs. Blood was collected by cardiac puncture and red blood cells were lysed and remaining leukocytes stained for cell sorting. All cells sorted were B220 À and NK1.1 À to exclude B cells and NK cells that readily attach to monocytes. Propidium iodide excluded dead cells. The entire procedure from the time mice were euthanized to direct collection of cells after the second sort in TRIZOL was <3 hr.
Immunostaining
Immunostaining of tissue sections was carried out with appropriate isotypematched controls or biotinylated anti-Ly-6C mAb and I-A and I-E mAbs from Biolegend, along with anti-COX-2 mAb (clone 33) from Sigma. Figures 3B and 3C ). Raw data were normalized with the robust multiarray algorithm. A common threshold for positive expression at 95% confidence across the data set was determined to be 120. Differentially expressed probe sets between populations were selected by a Student's t test with Bonferroni correction (p < 0.05 and 2-fold change). Signature transcripts were visualized by means of the ''Heat Map Viewer'' module of GenePattern (http:// www.broadinstitute.org/cancer/software/genepattern/). Pathway enrichment signatures were identified with List2Network software (http://amp.pharm. mssm.edu/lachmann/upload/register.php). Principal component analysis (PCA) was conducted with MATLAB with RMA-normalized and log2-transformed expression data.
Bone Marrow Transplants
Monocyte-Endothelial Cell Interactions
Ly-6C + MHCII -monocytes were isolated from Cx3cr1 gfp/gfp spleens via negative selection with anti-CD3, anti-B220, anti-MHCII, anti-CD11c, anti-Ly6G, and anti-siglec F magnetic beads (Miltenyi). Analysis of monocyte purity was performed by flow cytometry analysis. A bovine type-1 collagen (Advanced Biomatrix) bed was prepared in microplates.Bend.3 endothelial cells, kindly provided by J. Jacobelli at National Jewish Health, were placed atop the collagen to achieve confluency. 1 3 10 6 enriched monocytes were added to endothelial-collagen wells and cocultured for 18 hr at 37 C. Monocytes were retrieved by adding collagenase D to digest the collagen before staining and flow cytometry analysis with gating on monocytes. Control wells used 3T3 and primary lung fibroblasts instead of endothelium
Statistics
Statistical analysis by one-way ANOVA or two-tailed Student's t test was conducted with InStat and Prism software (GraphPad Software). All results are expressed as mean ± SEM. A value of p < 0.05 was considered significant.
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